Tag: Medias-en
-
The MENA H Coalition calls for sustained investments in the fight against tuberculosis in the MENA region
Joint press release FOR IMMEDIATE RELEASE MENA-H coalition urges urgent action to combat tuberculosis in the region, with emphasis on innovation and universal health coverage 2025, March 24 – On World Tuberculosis Day, the MENA-H Coalition issues an urgent call to intensify efforts to eliminate tuberculosis (TB) in the Middle East and North Africa (MENA)…
-
Results of a study on lenacapavir and two broadly neutralizing antibodies were presented at CROI 2025.
At the Conference on Retroviruses and Opportunistic Infections (CROI 2025) in San Francisco, results were presented from a Phase II study examining the efficacy of a combination of lenacapavir (TN Sunlenca) and two broadly neutralizing antibodies (bNAbs) – teropavimab and zinlirvimab. The study results indicate that this regimen could form the basis of a complete…
-
ITPC-MENA at the Mediterranean Symposium on HIV and Hepatitis (AFRAMED 2017)
ITPC-MENA at 2nd Mediterranean Symposium on HIV and Hepatitis (AFRAMED 2017) Join ITPC-MENA at AFRAMED 2017 – Hammamet Join ITPC_MENA at 2nd Mediterranean Symposium on HIV and Hepatitis (AFRAMED 2017) in Tunis and Hammamet from 27 – 30 September 2017. We are co-hosting and participating in many sessions. Check out our flyer below for our full…
-
Job offer for the MENA regional platform manager on Global Fund and Civil Society
JOB DESCRIPTION: REGIONAL GLOBAL FUND PLATFORM MANAGER ABOUT ITPC-MENA: International Treatment Preparedness Coalition (ITPC) Middle East & North Africa (MENA) is a regional non governmental organization operating in the Middle East and North Africa region regrouping a network of community activists united by our vision of a longer, healthier, more productive life for people living…
-
2nd Francophone Symposium AFRAMED on HIV and Hepatitis
2nd Francophone Symposium AFRAMED on HIV and Hepatitis September 28 to 30, Hammamet, Tunisie Following the success of the first experience in Algeria, the second edition of AFRAMED symposium will be hosted by Tunisia. This AFRAMED edition is in line with mobilizations for the success of 90-90-90 goals to put an end at the VIH…
-
IAS 2017: Closing ceremony exposes Gilead Sciences
Conference funders, Gilead Sciences, named and shamed for its “insatiable greed” Yesterday, the 9th International AIDS Conference on HIV Science in Paris (IAS 2017), drew to a close, in style. The community address delivered by Othoman Mellouk, during the closing ceremony, exposed one of the key conference sponsors, Gilead. Mellouk, who is the Intellectual Property…
-
US Supreme Court Adopts International Exhaustion For Patents: Paving the way for parallel imports to exert downward pressure on domestic pharmaceutical (and other) prices
Source : By Frederick M The Supreme Court of the United States on May 30, 2017 adopted a rule of international exhaustion of patent rights for the United States in Impression Products v. Lexmark International, No. 15-1189. The near-unanimous decision authored by Chief Justice Roberts is unambiguous and unequivocal.[1] The Court paid short shrift to…
-
M-Coalition launch a new guide: Key Population Engagement in Global Fund Country Dialogue CCMs and the 2017-‐2019 funding cycle
Source : M-Colaition This resource guide is designed to assist civil society organizations in understanding how to access funding from the Global Fund (GF) and effectively engage in country dialogue through all the key stages. In 2014, the Global Fund’s New Funding Model (NFM) was launched. Inclusion of civil society and key affected populations (KAP)…
-
Morocco: Creation of a collective for t the right to health in the framework of the negotiations of the EU ALECA
At a time when the Kingdom of Morocco and the European Union are preparing to resume negotiations on the “comprehensive and thorough free trade agreement” (FTAA), Moroccan civil society unites to bell Alarm about ALECA’s danger of access to generics in our country. A collective for the preservation of the right to health in Morocco in…
-
Pharma Refuses to Ensure Access to Lifesaving Hepatitis C Treatment at Global Meeting
Bangkok, Thailand, February 28, 2014 —Thirty-eight activists from 22 countries joined forces at the first-ever Hepatitis C Virus (HCV) World Community Advisory Board (CAB) to demand equitable access to treatment for hepatitis C virus (HCV) from six multinational pharmaceutical companies. Yet AbbVie, Bristol-Myers Squibb, Gilead, Janssen, Merck, and Roche refused to provide a plan for…